Skip to content

Medco Health Solutions

Controversies

Controversies tied to this brand in public sources. A listing is not a finding of fault.

Back to profile3 entries

  1. 2024

    Oklahoma insulin-pricing lawsuit names drug manufacturers and pharmacy benefit managers

    Lawsuit filed

    In May 2024, Oklahoma Attorney General Gentner Drummond filed a lawsuit against named drug manufacturers and pharmacy benefit managers, alleging unfair insulin prices. The suit claimed that manufacturers and pharmacy benefit managers coordinated to control drug prices and purchasing behavior. The allegations were reported as claims in the filing and were not presented as a court determination. Medco Health Solutions is identified among the pharmacy benefit managers named in the event.

    Source excerpt

    • The defendants are: Eli Lilly and Company Novo Nordisk Inc Sanofi-Aventis U.S. LLC Evernorth Health Inc. (formerly Express Scripts Holding Co.) Express Scripts Inc. Express Scripts Administrators LLC Esi Mail Pharmacy Service Inc. Express Scripts Pharmacy Inc. Medco Health Solutions Inc. CVS Health Corp. CVS Pharmacy Inc. Caremark Rx LLC Caremarkpcs Health LLC Caremark LLC Unitedhealth Group Inc Optumrx Inc. Optuminsight Inc.
    • Drummond claims manufacturers and PBMs coordinated to control drug prices and purchasing behavior.
    • “The outrageous profits these companies obtained through deceptive business practices need to be paid back through restitution or rescission.”
  2. 2005

    Federal kickback and false-claims settlement

    Medco agreed to pay the United States $155 million plus interest to resolve allegations that it accepted kickbacks from drug manufacturers and submitted false claims to the government. The settlement did not include an admission of guilt.

  3. 2004

    Multistate allegations concerning incentives and medication switching

    Twenty states alleged that Medco failed to disclose incentives received from pharmaceutical companies and improperly switched or pressured physicians to switch patients’ medicines, potentially increasing health-plan costs. Medco agreed to pay $29.3 million to settle the case without admitting guilt or accepting a finding of wrongdoing.